儿童及青年连续肾脏替代治疗与生存:WE-ROCK多国协作研究
该回顾性多中心队列纳入7国32中心2015–2021年980例接受CKRT的0–25岁患者,中位年龄8.8岁,64.1%存活至ICU出院,CKRT剂量、滤器类型及抗凝方式与生存未见关联,但存在机构间实践差异。
要点
- 儿童及青年CKRT患者约三分之二存活至ICU出院。
- CKRT剂量、滤器类型及抗凝方式与生存未检测到关联。
- 实践存在机构ICU规模相关的差异。
核心结论
- 在接受CKRT的儿童及青年中,约三分之二至少存活至ICU出院。
- 虽观察到透析模式、剂量、导管尺寸与位置及抗凝的差异,但生存未检测到与这些参数相关。
研究设计与样本
- 回顾性多中心队列研究,纳入7国32中心2015–2021年980例出生至25岁接受CKRT的患者。
主要发现
- 中位年龄8.8岁(IQR 1.6–15.0),中位体重26.8 kg(IQR 11.6–55.0)。
- CKRT在ICU入住后中位2天(IQR 1–6)启动,中位持续6天(IQR 3–14)。
- 最常见模式为连续静脉-静脉血液透析滤过,62%使用枸橼酸抗凝,66%导管置入颈内静脉。
- 629例(64.1%)至少存活至ICU出院。
- 存活与未存活至ICU出院者的CKRT剂量、滤器类型及抗凝相似。
临床怎么用
- 儿童及青年CKRT管理可参考本队列中连续静脉-静脉血液透析滤过及枸橼酸抗凝的较高使用比例。
- 机构间实践差异提示需关注ICU规模对CKRT处方的影响。
局限性
- 回顾性设计。
- 美国以外中心代表性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: There are limited studies describing the epidemiology and outcomes in children and young adults receiving continuous kidney replacement therapy (CKRT). We aimed to describe associations between patient characteristics, CKRT prescription, and survival. STUDY DESIGN: Retrospective multicenter cohort study. SETTING & PARTICIPANTS: 980 patients aged from birth to 25 years who received CKRT between 2015 and 2021 at 1 of 32 centers in 7 countries participating in WE-ROCK (Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Diseases). EXPOSURE: CKRT for acute kidney injury or volume overload. OUTCOMES: Death before intensive care unit (ICU) discharge. ANALYTICAL APPROACH: Descriptive statistics. RESULTS: Median age was 8.8 years (IQR, 1.6-15.0), and median weight was 26.8 (IQR, 11.6-55.0) kg. CKRT was initiated a median of 2 (IQR, 1-6) days after ICU admission and lasted a median of 6 (IQR, 3-14) days. The most common CKRT modality was continuous venovenous hemodiafiltration. Citrate anticoagulation was used in 62%, and the internal jugular vein was the most common catheter placement location (66%). 629 participants (64.1%) survived at least until ICU discharge. CKRT dose, filter type, and anticoagulation were similar in those who did and did not survive to ICU discharge. There were apparent practice variations by institutional ICU size. LIMITATIONS: Retrospective design; limited representation from centers outside the United States. CONCLUSIONS: In this study of children and young adults receiving CKRT, approximately two thirds survived at least until ICU discharge. Although variations in dialysis mode and dose, catheter size and location, and anticoagulation were observed, survival was not detected to be associated with these parameters. PLAIN-LANGUAGE SUMMARY: In this large contemporary epidemiological study of children and young adults receiving continuous kidney replacement therapy in the intensive care unit, we observed that two thirds of patients survived at least until ICU discharge. However, patients with comorbidities appeared to have worse outcomes. Compared with previously published reports on continuous kidney replacement therapy practice, we observed greater use of continuous venovenous hemodiafiltration with regional citrate anticoagulation.
引用
- Starr MC, Gist KM, Zang H, et al. Continuous Kidney Replacement Therapy and Survival in Children and Young Adults: Findings From the Multinational WE-ROCK Collaborative. Am J Kidney Dis. 2024. PMID: 38364956. doi:10.1053/j.ajkd.2023.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。